Non-coding RNAs and respiratory disease

Thorax

Volumn 70, Issue 4, 2015, Pages 388-390

  Mestdagh, Pieter ^a   Vandesompele, Jo ^a   Brusselle, Guy ^a,b   Vermaelen, Karim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

UNTRANSLATED RNA; BIOLOGICAL MARKER;

ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; FIBROSING ALVEOLITIS; HUMAN; LUNG CANCER; LUNG DISEASE; LUNG EMPHYSEMA; PRIORITY JOURNAL; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES; RESPIRATION DISORDERS;

BIOLOGICAL MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR TARGETED THERAPY; RESPIRATION DISORDERS; RNA, UNTRANSLATED;

EID: 84925639830     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206404     Document Type: Article

References (5)

1. Liu G, Mattick JS, Taft RJ. A meta-Analysis of the genomic and transcriptomic composition of complex life. Cell Cycle 2013; 12: 2061-72.
2. White NM, Cabanski CR, Silva-Fisher JM, et al. Transcriptome sequencing reveals altered long intergenic non-coding RNAs in lung cancer. Genome Biol 2014; 15: 429.
3. Booton R, Lindsay MA. Emerging role of microRNAs and long noncoding RNAs in respiratory disease. Chest 2014; 146: 193-204.
4. Guo Z, Zhao C, Wang Z. MicroRNAs as ideal biomarkers for the diagnosis of lung cancer. Tumour Biol 2014; 35: 10395-407.
5. Janssen HLA, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368: 1685-94.